• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Breast Cancer Treatment Drug Markets in China

  • ID: 682815
  • July 2015
  • Region: China
  • 227 pages
  • AMID Co
China's demand for Breast Cancer Treatment Drug will continue to grow at 12% by 2024

China's demand for Breast Cancer Treatment Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2004, 2009 and 2014) and long-term forecasts through 2019 and 2024 are presented.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are READ MORE >

Note: Product cover images may vary from those shown
China's demand for Breast Cancer Treatment Drug will continue to grow at 12% by 2024

I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT

Economic Outlook

Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade

Financial and Tax Regulations

Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. BREAST CANCER TREATMENT DRUG INDUSTRY ASSESSMENTS

Breast Cancer Treatment Drug Industry Structure
Market Size
Market Growth Driver
Breast Cancer Treatment Drug Sales Volume
Major Producer Facility Locations
Major Producers’ Sales Volume and Market Share
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investments
Technology Development

IV. BREAST CANCER TREATMENT DRUG PRODUCTION AND DEMAND

Overview
Breast Cancer Treatment Drugs Sales Volume
Chemotherapeutic Drug
Paclitaxel
Fluoropyrimidines
Anthracycline Antibiotics
Targeted Therapy Drug
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)
Endocrine Therapy Drug
Anti-estrogens
Progesterone
Aromatase Inhibitors (Endocrine Therapy Drug)
LH-RH
Breast Cancer Treatment Drugs Import
Chemotherapeutic Drug
Paclitaxel
Fluoropyrimidines
Anthracycline Antibiotics
Targeted Therapy Drug
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)
Endocrine Therapy Drug
Anti-estrogens
Progesterone
Aromatase Inhibitors (Endocrine Therapy Drug)
LH-RH
Pricing Trend

V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK

Breast Cancer Treatment Drug Markets Outlook Overview Concrete Government Regulations
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

VI. MARKET ENTRY CHANNELS

China Market Entry Overview
China’s Distribution System
Breast Cancer Treatment Drug Distribution Channels
Transportation and Freight Infrastructure
Communications

China’s Market Entry
Licensing
Franchising
E-commerce
Trading Companies and Local Agents
Representative Offices and Chinese Subsidiaries
Wholly Foreign Owned Enterprises

VII. ANTIFREEZE & THAWING AGENT PRODUCER DIRECTORY

Breast Cancer Treatment Drug Producer Profiles and Directory

LIST OF TABLES

I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. BREAST CANCER TREATMENT DRUG INDUSTRY ASSESSMENTS

Breast Cancer Treatment Drug Sales Volume
Major Producer Facility Locations
Major Breast Cancer Treatment Drug Producer Sales Volume and Market Share
Major Foreign Investments

IV. BREAST CANCER TREATMENT DRUG PRODUCTION AND DEMAND

Total Breast Cancer Treatment Drugs Sales Volume
Breast Cancer Treatment Drug Major Producer and Their Market Share
Chemotherapeutic Drug Major Producer and Their Market Share
Paclitaxel Major Producer and Their Market Share
Fluoropyrimidines Major Producer and Their Market Share
Anthracycline Antibiotics Major Producer and Their Market Share
Targeted Therapy Drug Major Producer and Their Market Share
Therapertic Antibody Major Producer and Their Market Share
Small Molecules Drug Major Producer and Their Market Share
Aromatase Inhibitors (Targeted Therapy Drug) Major Producer and Their Market Share
Endocrine Therapy Drug Major Producer and Their Market Share
Anti-estrogens Major Producer and Their Market Share
Progesterone Major Producer and Their Market Share
Aromatase Inhibitors (Endocrine Therapy Drug) Major Producer and Their Market Share
LH-RH Major Producer and Their Market Share
Breast Cancer Treatment Drugs Import

V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK

Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

Breast Cancer Treatment Drug Sales Volume

II. BUSINESS ENVIRONMENT

China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports

III. ANTIFREEZE & THAWING AGENT INDUSTRY ASSESSMENTS

Chemotherapeutic Drug Sales Volume by Drugs Classification
Targeted Therapy Drug Sales Volume by Drugs Classification
Endocrine Therapy Drug Sales Volume by Drugs Classification
Breast Cancer Treatment Drug Sales Volume

IV. ANTIFREEZE & THAWING AGENT PRODUCTION AND DEMAND

Breast Cancer Treatment Drug Sales Volume
Chemotherapeutic Drug Sales Volume and Market Share
Chemotherapeutic Drug Sales Volume by Drugs Classification
Paclitaxel Sales Volume and Market Share
Fluoropyrimidines Sales Volume and Market Share
Anthracycline Antibiotics Sales Volume and Market Share
Targeted Therapy Drug Sales Volume and Market Share
Targeted Therapy Drug Sales Volume by Drugs Classification
Therapertic Antibody Sales Volume and Market Share
Small Molecules Drug Sales Volume and Market Share
Aromatase Inhibitors (Targeted Therapy Drug) Sales Volume and Market Share
Endocrine Therapy Drug Sales Volume and Market Share
Endocrine Therapy Sales Volume by Drugs Classification
Anti-estrogens Sales Volume and Market Share
Progesterone Sales Volume and Market Share
Aromatase Inhibitors (Endocrine Therapy Drug) Sales Volume and Market Share
LH-RH Sales Volume and Market Share
Breast Cancer Treatment Drugs Import
Chemotherapeutic Drug Import and Market Share
Chemotherapeutic Drug Import by Drugs Classification
Paclitaxel Import and Market Share
Fluoropyrimidines Import and Market Share
Anthracycline Antibiotics Import and Market Share
Targeted Therapy Drug Import and Market Share
Targeted Therapy Drug Import by Drugs Classification
Therapertic Antibody Import and Market Share
Small Molecules Drug Import and Market Share
Aromatase Inhibitors (Targeted Therapy Drug) Import and Market Share
Endocrine Therapy Drug Import and Market Share
Endocrine Therapy Drug Import by Drugs Classification
Anti-estrogens Import and Market Share
Progesterone Import and Market Share
Aromatase Inhibitors (Endocrine Therapy Drug) Import and Market Share
LH-RH Import and Market Share

V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK
Breast Cancer Treatment Drugs Demand by Market

VI. MARKETING STRATEGIES

China’s Distribution Channel

Note: Product cover images may vary from those shown
China's demand for Breast Cancer Treatment Drug will continue to grow at 12% by 2024

- Wyeth China Inc.
- Shenzhen Main Luck Pharmaceuticals Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S